Navigation Links
Circulating Tumor Cells (CTCs) Prognostic Technologies Market Expected to Reach USD 2.16 Billion Globally in 2020
Date:7/22/2014

Albany, New York (PRWEB) July 22, 2014

According to a new market report published by Transparency Market Research “Circulating Circulating Tumor Cells (CTCs) Prognostic Technologies Market [Technologies: Tumor Cell Enrichment (Filtration, Centrifugation and Immunological & Immunomagnetic Methods) & Tumor Cell Detection (Molecular Methods and Optical Methods) and Applications: Prostate Cancer, Breast Cancer, Colorectal Cancer and Others] - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020,” the global circulating tumor cells (CTCs) prognostic technologies market was valued at USD 0.43 billion in 2013 and is expected to grow at a CAGR of 26.3% from 2014 to 2020, to reach an estimated value of USD 2.16 billion in 2020.

Title: Circulating Circulating Tumor Cells (CTCs) Prognostic Technologies Market
Published: June 2014
Pages: 100
Price:    US$ 4,795.00 (Single User)
For further inquiries, click here:     http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2497

Circulating tumor cells (CTCs) are specialized rare cells, that have detached from the primary tumors of the body and disseminated in the vasculature system of the body, eventually causing metastasis. CTCs are composed of particular cells that act as seeds for successive development of additional metastatic tumors in essential distant organs, which is liable for the majority of cancer-related deaths. CTCs are not easily detected since these cells are present in less numbers in the blood stream. Therefore, detection of CTCs during the progression of the tumor provides a prognostic value of the tumor progression as well as evaluates t
'/>"/>

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. A few circulating cancer cells could cue risk of metastases
2. New technology using florescent proteins tracks cancer cells circulating in the blood
3. NCCS and Clearbridge Biomedics open the regions first circulating tumor cell center
4. Circulating tumor cells in blood can predict a patients response to chemotherapy
5. New research finds flu shot effective regardless of circulating flu strain
6. Sous Vide Circulating Bath Systems Enable Chefs to Achieve Perfect Results
7. Detecting circulating tumor cells
8. New technology allows scientists to capture and preserve cancer cells circulating in the bloodstream
9. Capturing circulating cancer cells could provide insights into how disease spreads
10. Described novel regulator of a protein inactive in over 50 percent of human tumors
11. New combination drug controls tumor growth and metastasis in mice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who consistently delivers ... to have it lead the wedding dress industry into the ... dresses for the global market. , “The CEO of VogueQueen ... focuses on continuing the goal of operational excellence and giving ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The federal court ... the U.S. District Court, Southern District of West Virginia has ... in that proceeding’s first bellwether trial. In an Order dated ... new trial after finding that C.R. Bard had not proven ...
(Date:1/22/2015)... Oceanside,CA (PRWEB) January 22, 2015 For over 20 ... the Oceanside and Vista area has treated just about ... other personal injury circumstances. And for those same twenty-plus years, ... victims of all those injuries with the best possible doctor. ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne wedding ... annual revenues in the past three years. Today, the business ... , According to the sales manager of the company, this ... in 2015. This point can be reflected on the discounted ...
(Date:1/22/2015)... 2015 As interest in the value of ... momentum worldwide, Rev. Eric J. Hall , president and ... (HCCN), will be the keynote speaker on January 27 at ... health system. , The conference, “Hope and Resilience: Innovative and ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3
... discovered a potential new drug target for Multiple Sclerosis that ... new drug is developed. In the first phase ... of their brain cells, resulting in continuous cycles of inflammation ... of the disease, the inflammation isn,t as severe, but this ...
... By Alan Mozes HealthDay Reporter , WEDNESDAY, Oct. 26 ... made even walking a short distance an agony; a 20-year-old man ... ventilator; a woman with a potentially fatal buildup of a protein ... diagnose, let alone treat. And yet all of these ...
... , WEDNESDAY, Oct. 26 (HealthDay News) -- Moving ... music better, according to a new study. Researchers at ... for study participants, half of whom tapped on an electronic ... without tapping. The participants were asked whether the final ...
... , WEDNESDAY, Oct. 26 (HealthDay News) -- ... adults and teenagers in the United States, the U.S. ... as another National Prescription Drug Take-Back Day. ... to a 2009 survey from the U.S. Substance Abuse ...
... as comfortable with white light generated by diode lasers ... (LEDs), according to tests conceived at Sandia National Laboratories. ... generate light, but the simpler LED emits lights only ... forth internally before releasing it. The finding is ...
... estimate, half of Americans are confronting a civil legal problem at ... advice, or an advocate in civil court, they may lose a ... They may lose out in a divorce, or in a billing ... those services depends not on their need but where they live, ...
Cached Medicine News:Health News:Medical researchers ID potential new drug target that could stop debilitating effects of MS 2Health News:For Those With Mystery Illnesses, a 'Clinic of Last Resort' 2Health News:For Those With Mystery Illnesses, a 'Clinic of Last Resort' 3Health News:For Those With Mystery Illnesses, a 'Clinic of Last Resort' 4Health News:National Drug Take-Back Day Scheduled for Saturday 2Health News:High-quality white light produced by four-color laser source 2Health News:High-quality white light produced by four-color laser source 3Health News:Access to legal aid depends a lot on where you live, report says 2Health News:Access to legal aid depends a lot on where you live, report says 3
(Date:1/23/2015)... Jan. 23, 2015  HyGreen, Inc., a leader in hand ... with RCA Medical, a subsidiary of Ascendis Health Limited, ... Each year, hundreds of millions of patients around ... organisms are transmitted from patient to patient via the ...
(Date:1/23/2015)... N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. ... its Phase I trial of Lixte,s lead compound, LB‑100, is ... John S. Kovach , M.D., the founder ... planned to be completed at a single site. Accrual of ...
(Date:1/23/2015)... Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), ... extracorporeal cytokine adsorber to reduce deadly inflammation in ... of $385,642, net of transaction costs, in non-dilutive ... Business Tax Certificate Transfer Program sponsored by the ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
Cementless hip stem revisions offering optimal version setting for each patient. Compatible with modular link ceramic or cobalt chromium femoral heads with up to 4 neck lengths, or the link saddle de...
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Medicine Products: